CORD-19:c738a511a9c18e7e831b40f1ec3605fe4cdeb6d1 / 15518-15618 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T98","span":{"begin":0,"end":100},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Neoadjuvant chemotherapy (NAC), triple negative breast cancer (TNBC), lymphovascular invasion (LVI)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T98","span":{"begin":0,"end":100},"obj":"Sentence"}],"text":"Neoadjuvant chemotherapy (NAC), triple negative breast cancer (TNBC), lymphovascular invasion (LVI)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T30","span":{"begin":48,"end":61},"obj":"Phenotype"}],"attributes":[{"id":"A30","pred":"hp_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"Neoadjuvant chemotherapy (NAC), triple negative breast cancer (TNBC), lymphovascular invasion (LVI)."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T50","span":{"begin":48,"end":54},"obj":"Body_part"}],"attributes":[{"id":"A50","pred":"uberon_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Neoadjuvant chemotherapy (NAC), triple negative breast cancer (TNBC), lymphovascular invasion (LVI)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T83","span":{"begin":32,"end":61},"obj":"Disease"},{"id":"T84","span":{"begin":48,"end":61},"obj":"Disease"},{"id":"T85","span":{"begin":55,"end":61},"obj":"Disease"},{"id":"T86","span":{"begin":63,"end":67},"obj":"Disease"},{"id":"T73891","span":{"begin":32,"end":61},"obj":"Disease"},{"id":"T98749","span":{"begin":48,"end":61},"obj":"Disease"},{"id":"T89990","span":{"begin":55,"end":61},"obj":"Disease"},{"id":"T84376","span":{"begin":63,"end":67},"obj":"Disease"}],"attributes":[{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0005494"},{"id":"A84","pred":"mondo_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A85","pred":"mondo_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A86","pred":"mondo_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/MONDO_0005494"},{"id":"A8495","pred":"mondo_id","subj":"T73891","obj":"http://purl.obolibrary.org/obo/MONDO_0005494"},{"id":"A55495","pred":"mondo_id","subj":"T98749","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A9770","pred":"mondo_id","subj":"T89990","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A58904","pred":"mondo_id","subj":"T84376","obj":"http://purl.obolibrary.org/obo/MONDO_0005494"}],"text":"Neoadjuvant chemotherapy (NAC), triple negative breast cancer (TNBC), lymphovascular invasion (LVI)."}